ED vs HBIO · P/E 18, rev $16.92B vs rev $22.7M
Consolidated Edison Inc (ED) versus Harvard Bioscience Inc (HBIO) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Latest reported ED revenue for 2025-12-31 was $16.92B. Net income was $2.02B. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. HBIO currently screens at market cap $20.3M.
Not investment advice. Open the ED and HBIO stock pages for the full models.
Not investment advice.